Moffitt leads the nation in addressing LGBTQ health care disparities and education

January 16, 2019

TAMPA, Fla. (Jan. 16, 2018) -- The lesbian, gay, bisexual, transgender and queer/questioning (LGBTQ) community has long been a medically underserved minority population in the United States. Disparities experienced by LGBTQ patients, especially in cancer care, can lead to poorer outcomes and overall health. Moffitt Cancer Center is leading the nation in addressing the issues facing this group of patients through research and the creation of new educational programs.

Moffitt launched the first nationwide survey to identify potential gaps in attitudes, knowledge and institutional practices for LGBTQ patients. The results were published today in the Journal of Clinical Oncology. The research team, led by Matthew Schabath, Ph.D., surveyed 450 oncologists from 45 National Cancer Institute-designated cancer centers and received 149 (33.1 percent) responses. The results show that while a majority of oncologists (95.3 percent) were comfortable treating lesbian, gay and bisexual patients, only half (53.1 percent) were confident they knew the health needs of that patient population. And that number dropped dramatically for transgender patients; just over a third of oncologists (36.9 percent) surveyed felt they understood the needs of transgender patients.

Other key findings include:

"Three to 12 percent of the U.S. adult population identifies as LGBTQ. Studies show the LGBTQ population has an increased risk and poorer outcomes for certain cancers, but despite that increased risk, they are less likely to go to the doctor for screenings. This group also reported lower satisfaction with cancer care," said Schabath, lead study author. "Our survey identified there is need and a desire among oncologists for education and training about LGBTQ patients."

Utilizing the information gathered in the survey, Moffitt researchers teamed with Sylvester Comprehensive Cancer Center at the University of Miami and UF Health Cancer Center at the University of Florida to create an online cultural competency training program to improve knowledge of LGBTQ-related issues among the cancer care community.

The Curriculum for Oncologists on LGBTQ populations to Optimize Relevance and Skills, or COLORS Training Program for short, contains four 30-minute modules. Two modules cover general topics, such as sexual orientation and gender identity. The remaining two modules discuss oncology-focused topics, including fertility and hormone therapy for LGBTQ patients undergoing cancer treatment.

"The COLORS training program can substantially improve oncologists' knowledge and attitudes regarding LGBT cancer patients, which in turn can lead to better care for this patient population," said Schabath.

In the pilot study, 20 Florida oncologists participated in the online training and provided feedback. The oncologists ranged in age from 38 to 71, and three-quarters of them identified as heterosexual and cisgender (people whose gender identity match the sex they were assigned at birth).

Prior to online training 33 percent of participants could answer more than 90 percent of the LGBTQ knowledge items correctly. After training that finding jumped to 85 percent. And 95 percent of the group said they would refer another oncologist to the training.
-end-
The survey study was supported by a Miles for Moffitt Milestone Award and Moffitt's Cancer Center Support Grant from the National Cancer Institute. Funding for the COLORS Training Program was provided by the Florida Academic Cancer Center Alliance. The researchers are seeking additional funding to expand the training program to reach oncologists across the U.S.

About Moffitt Cancer Center

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 49 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's scientific excellence, multidisciplinary research, and robust training and education. Moffitt is a Top 10 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt devotes more than 2 million square feet to research and patient care. Moffitt's expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 6,000 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter and YouTube.

H. Lee Moffitt Cancer Center & Research Institute

Related Cancer Care Articles from Brightsurf:

Black lives also matter in cancer care
It is not biology, but access to health care that is causing Black Non-Hispanic patients with squamous cell cancer of the head and neck to have lower survival rates.

Cancer vs. COVID: When a pandemic upended cancer care
A team of researchers interviewed physicians and patients at the beginning of the COVID-19 pandemic to identify eight scenarios impacting cancer care.

Prioritizing cancer care during pandemic
The COVID-19 pandemic has forced oncology clinicians and administrators in the United States to set priorities for cancer care because of resource constraints.

Supportive care to relieve cancer-related fatigue underutilised by breast cancer survivors
Cancer-related fatigue is a prevalent and potentially persistent issue among breast cancer survivors, which can prevent them from returning to their previous life well after treatment ends and they are declared free of disease.

After cancer: The role of primary care in cancer survivorship care
Primary care physicians are treating an increasing number of cancer survivors, yet they have no clear guidance on how best to care for such patients.

Lung cancer screening in primary care
The benefits of routine lung cancer screenings have been hotly debated in the medical community.

Palliative care for patients with cancer in COVID-19 era
The considerations and challenges affecting the palliative care specialty and delivery of palliative care in the COVID-19 era, as well as potential solutions, are discussed in this Viewpoint.

Cancer care needs mass COVID-19 testing
Thousands of cancer patients in the UK have had their treatment stopped or delayed because of COVID-19, and with pressures mounting on the health service, Cancer Research UK calls for widespread testing to prevent unnecessary cancer deaths.

Cancer care in the time of COVID-19
Below please find link(s) to new coronavirus-related content published today in Annals of Internal Medicine.

JNCCN: How to manage cancer care during COVID-19 pandemic
Experts from Seattle Cancer Care Alliance share lessons learned from early experiences treating people with cancer during COVID-19 outbreak via free online article in JNCCN--Journal of the National Comprehensive Cancer Network

Read More: Cancer Care News and Cancer Care Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.